Huakang Biomedical Holdings Company Limited (stock code: 08622) has released its monthly return for January 2026. According to the filing, the authorized share capital remains 1,000,000,000 ordinary shares at a par value of HKD 0.01 each, amounting to HKD 10,000,000 in total, with no change from the previous month.

The total number of issued shares also remains at 515,472,000. No movement was recorded in issued shares, treasury shares, or any convertible instruments. The company confirms that the minimum public float threshold of 25% has been met as of the end of January 2026.